Phase 2 study of dalantercept in recurrent or metastatic squamous cell carcinoma of the head and neck

被引：2
|
作者：
Jimeno, Antonio
Posner, Marshall R.
Weiss, Jared
Wirth, Lori J.
Saba, Nabil F.
Cohen, Roger B.
Popa, Elizabeta C.
Argiris, Athanassios
Grossmann, Kenneth F.
Sukari, Ammar
Korth, Chris
Wilson, Dawn
McClure, Ty
Alimzhanov, Marat
Pearsall, Scott
Attie, Kenneth M.
Sherman, Matthew L.
Pandya, Shuchi Sumant
机构：
[1] Univ Colorado Denver, Aurora, CO USA
[2] Icahn Sch Med Mt Sinai, Dept Hematol & Med Oncol, New York, NY 10029 USA
[3] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[7] Weill Cornell Med Coll, New York, NY USA
[8] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[9] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[10] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[11] Acceleron Pharma, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.6045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6045
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tang, Patricia A.
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Pond, Gregory R.
    Johnson, Caitlin
    Colevas, A. Dimitrios
    Synold, Timothy W.
    Vasist, Lakshmi S.
    Winquist, Eric
    [J]. INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 257 - 264
  • [2] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [3] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Patricia A. Tang
    Lillian L. Siu
    Eric X. Chen
    Sebastien J. Hotte
    Stephen Chia
    James K. Schwarz
    Gregory R. Pond
    Caitlin Johnson
    A. Dimitrios Colevas
    Timothy W. Synold
    Lakshmi S. Vasist
    Eric Winquist
    [J]. Investigational New Drugs, 2008, 26 : 257 - 264
  • [4] A Phase 2 Study of Dalantercept, an Activin Receptor-Like Kinase-1 Ligand Trap, in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Jimeno, Antonio
    Posner, Marshall R.
    Wirth, Lori J.
    Saba, Nabil F.
    Cohen, Roger B.
    Popa, Elizabeta C.
    Argiris, Athanassios
    Grossmann, Kenneth F.
    Sukari, Ammar
    Wilson, Dawn
    Zhang, Xiaosha
    Sun, Jade
    Glasser, Chad
    Attie, Kenneth M.
    Sherman, Matthew L.
    Pandya, Susan S.
    Weiss, Jared
    [J]. CANCER, 2016, 122 (23) : 3641 - 3649
  • [5] A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Lee, Ji Hyun
    Heo, Seong Gu
    Ahn, Beung-Chul
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    Kim, Hye Ryun
    [J]. CANCER MEDICINE, 2021, 10 (20): : 7012 - 7020
  • [6] Phase II study of dalantercept, a novel inhibitor of ALK1-mediated angiogenesis, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Jimeno, Antonio
    Wirth, Lori J.
    Posner, Marshall R.
    Cohen, Roger B.
    Weiss, Jared
    Popa, Elizabeta C.
    Saba, Nabil F.
    Grossmann, Kenneth F.
    Sukari, Ammar
    Cohen, Ezra E. W.
    Argiris, Athanassios
    Condon, Carolyn H.
    Wilson, Dawn
    McClure, Ty
    Alimzhanov, Marat
    Pearsall, Scott
    Attie, Kenneth M.
    Sherman, Matthew L.
    Pandya, Shuchi Sumant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    [J]. NATURE MEDICINE, 2023, 29 (04) : 880 - 887
  • [8] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [9] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
12345